Skip to main content
Fig. 7 | Journal of Nanobiotechnology

Fig. 7

From: Augmented EPR effect post IRFA to enhance the therapeutic efficacy of arsenic loaded ZIF-8 nanoparticles on residual HCC progression

Fig. 7

Biosafety assessment of the As@ZIF-8 NPs. A Blood analysis of alanine aminotransferase (ALT), alkaline phosphatase (ALP), total protein (TP), albumin (ALB), creatinine (Cr), uric acid (UA), triglyceride (TG), total cholesterol (TC), high density lipoprotein (HDL), and low density lipoprotein (LDL) levels after treatment with free ATO or As@ZIF-8 NPs. B Photographs showing HE staining of tissue sections in important organs, namely, the liver, lung, heart, spleen and kidney, of the mice after treatment with free ATO, As@ZIF-8 NPs, or ZIF-8 NPs. Scale bar, 100 µm

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us